Widely known for its oncology franchise, Celgene is expanding its medical applications to include inflammation, immune disorders and proprietary stemcell products derived from human placental cells.
The rationale for pursuing stemcell therapy in autism is based on encouraging results of unpublished data examining stemcell therapy in children with cerebral palsy, a group of disorders that affect not only movement, but learning, behavior and cognition.